Compass Therapeutics, Inc.

CMPX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Feb 11, 2025
SCHEDULE 13G Feb 4, 2025
SCHEDULE 13G Jan 16, 2025
4 Jan 13, 2025
8-K Jan 8, 2025 FORM 8-K
4 Dec 10, 2024
3 Dec 10, 2024
3 Dec 10, 2024
8-K Dec 10, 2024 FORM 8-K
SC 13G/A Nov 14, 2024 JANUS CLOSEOUT
10-Q Nov 12, 2024 FORM 10-Q
8-K Nov 12, 2024 FORM 8-K
EFFECT Sep 6, 2024
CORRESP Sep 4, 2024
UPLOAD Sep 3, 2024
S-3 Aug 30, 2024 S-3
4 Aug 14, 2024
10-Q Aug 12, 2024 FORM 10-Q
8-K Aug 12, 2024 FORM 8-K
3 Aug 9, 2024
SC 13G Aug 2, 2024 SC 13G
8-K Jun 17, 2024 FORM 8-K
DEFA14A May 29, 2024 DEFINITIVE ADDITIONAL MATERIALS
8-K May 28, 2024 FORM 8-K
10-Q May 13, 2024 FORM 10-Q
← Newer Page 5 of 15 · 359 filings Older →